REVENUES

DX Earnings Report: Q2 Lab Earnings Stay Strong but Not Quite at Q1 Levels

Q2 is shaping up to be another strong quarter—albeit not as stellar as Q1. Salient trends: Big labs continue posting impressive organic growth even as they enjoy the surge of new revenues from … [Read more...]

SPECIAL FOCUS

Cost Avoidance vs Cost Savings: What’s the Difference?

By Jennifer Dawson, MHA, DLM (ASCP)  bio As I work to spread awareness within the clinical laboratory community about the Cost of Poor Quality (COPQ) concept and its benefits as a method to … [Read more...]

EARNINGS

How to Avoid a Laboratory Audit

By Sean McSweeney  bio Laboratory audits have a much harder impact on your lab than intended. As detailed by the NCBI, the audit's intent is to review and assess laboratory performance to … [Read more...]

PAMA

PAMA Unlocks Golden Age for Innovative Diagnostics

By Chance Scott  bio The publication of the 2018 Clinical Laboratory Fee Schedule (CLFS) in January saw a long and heated debate within the lab community come to fruition. When Congress … [Read more...]

REVENUES

DX Earnings Report: PAMA Cuts Make Little Dent on Q1 Lab Earnings

One quarter into its existence, the new PAMA Medicare Part B fee schedule seems to be having only a marginal impact on at least publicly traded labs. In fact, the recently published Q1 earnings … [Read more...]

REVENUES

Dx Earnings Report: Strong Q4 as Lab Companies End Year with a Bang

Big PAMA cuts may lay ahead in 2017, but the diagnostics industry had a robust 2017. While the entire year was strong, success was the most widespread in the fourth quarter with all but a few … [Read more...]

REVENUES

Dx Earnings Report: Strong Q3 Adds to Robust 2017 as PAMA Looms for 2018

Big labs continue to post impressive earnings. But the positive Q3 numbers may prove to be the calm before the PAMA storm—at least for major reference labs that generate significant revenues from … [Read more...]

EARNINGS REPORTS

Dx Earnings Report: Strong Q2 Enables Lab Companies to Consolidate Q1 Gains

The lab industry consolidated its early 2017 gains with an almost equally strong Q2. Although there were some notable declines, most companies posted gains at or above Wall Street expectations. Here's … [Read more...]

EARNINGS REPORTS

Diagnostics Earnings Show Gains in 1st Q

The laboratory industry is off to a strong start in 2017. Although growth rates varied, most firms were up for the quarter. Here's an overview of 1Q 2017 based on the earnings reports we've seen so … [Read more...]

EARNINGS

Diagnostics Sector Reports 4Q Earnings

Fourth quarter earnings reports are starting to trickle in. Here is a big picture roundup of some of the key results so far. Gainers Companies with strong 4Q diagnostics revenues include: Abbott … [Read more...]


(-0000g2)